pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›approval
approval
save

OLANZAPINE — FDA approval

October 23, 2025olanzapine ODTupdated 5mo ago
community read0 votes

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

view source ↗
Data sources
fda approvals
last refreshed 5mo ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

drug timeline · 8

  • approvalOLANZAPINE — FDA approvalFeb 9, 2026 · 236d ago
  • approvalOLANZAPINE — FDA approvalFeb 9, 2026 · 236d ago
  • approvalOLANZAPINE — FDA approvalJan 22, 2026 · 254d ago
  • approvalOLANZAPINE — FDA approvalJan 6, 2026 · 270d ago
  • approvalOLANZAPINE — FDA approvalJan 6, 2026 · 270d ago
  • approvalOLANZAPINE — FDA approvalDec 3, 2025 · 304d ago
  • approvalOLANZAPINE — FDA approvalOct 23, 2025 · 345d ago
  • approvalOLANZAPINE — FDA approvalMar 12, 2024 · 935d ago

same company · ±60 days · 6

  • approvalondansetron hydrochloride CR: ONDANSETRON HYDROCHLORIDE — FDA approvalOct 23, 2025
  • approvalLINAGLIPTIN: LINAGLIPTIN — FDA approvalNov 3, 2025
  • approvaltopiramate ER: TOPIRAMATE — FDA approvalOct 7, 2025
  • approvalNAPROXEN: NAPROXEN — FDA approvalOct 3, 2025
  • approvalIRBESARTAN: IRBESARTAN — FDA approvalNov 12, 2025
  • approvalFOSFOMYCIN TROMETHAMINE: FOSFOMYCIN TROMETHAMINE — FDA approvalNov 14, 2025

🐶 often sniffed alongside

top 8
  • tagApproval598 co-mentions · 299 sources
  • drugLYBALVI444 co-mentions · 300 sources
  • drugolanzapine ER437 co-mentions · 300 sources
  • drugOLANZAPINE437 co-mentions · 300 sources
  • tagSmall Molecule239 co-mentions · 239 sources
  • drugOLANZAPINE AND FLUOXETINE HYDROCHLORIDE180 co-mentions · 60 sources
  • drugProzac120 co-mentions · 60 sources
  • drugfluoxetine hydrochloride DR120 co-mentions · 60 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?